Ernexa Therapeutics Inc. (ERNA)

Nasdaq · Pharmaceutical Preparations · Inc. DE

What they're doing

Between 2026-06-21 and 2026-09-19, public records show 2 signals for Ernexa Therapeutics Inc.. Most notable: 2026-06-26: Filed 8-K disclosing director or officer change; 2026-09-16: Filed 8-K disclosing director or officer change. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.

Generated 2026-09-19 from public records.

Signals, last 12 months

  1. Material 8-K filing
    Filed 8-K disclosing director or officer change
  2. Material 8-K filing
    Filed 8-K disclosing director or officer change
  3. Material 8-K filing
    Filed 8-K disclosing material agreement
  4. Insider purchase
    Cherington Charles (ten_percent_owner) bought $2.0M of stock

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2026-02-10Cherington Charlesten percent ownerP4,000,0000.5$2,000,000
2025-06-21Gurrola Sandra MofficerM30
2025-06-09Cherington Charlesten percent ownerP21,241,1630.1$2,124,116
2025-04-02Cherington Charlesten percent ownerP3,768,3970.1$376,840
2024-10-29Cherington Charlesten percent ownerP1,562,988
2024-10-29Cherington Charlesten percent ownerC2,819,5460.5$1,409,773
2024-10-29Cherington Charlesten percent ownerP4,768,783
2024-10-29Cherington Charlesten percent ownerP1,237,762
2024-10-29Cherington Charlesten percent ownerP5,420,823
2024-10-29Cherington Charlesten percent ownerP261,756
2024-09-24Cherington Charlesten percent ownerP1,562,988
2024-09-24Cherington Charlesten percent ownerP5,420,823
2024-09-24Cherington Charlesten percent ownerP1,237,762
2024-09-24Cherington Charlesten percent ownerP4,768,783
2024-09-24Cherington Charlesten percent ownerP261,756

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings